首页> 外文期刊>Journal of Medicinal Chemistry >Synthesis and anticancer mechanism investigation of dual Hsp27 and tubulin inhibitors
【24h】

Synthesis and anticancer mechanism investigation of dual Hsp27 and tubulin inhibitors

机译:Hsp27和微管蛋白双重抑制剂的合成及抗癌机制研究

获取原文
获取原文并翻译 | 示例
           

摘要

Heat shock protein 27 (Hsp27) is a chaperone protein, and its expression is increased in response to various stress stimuli including anticancer chemotherapy, which allows the cells to survive and causes drug resistance. We previously identified lead compounds that bound to Hsp27 and tubulin via proteomic approaches. Systematic ligand based optimization in the current study significantly increased the cell growth inhibition and apoptosis inducing activities of the compounds. Compared to the lead compounds, one of the new derivatives exhibited much better potency to inhibit tubulin polymerization but a decreased activity to inhibit Hsp27 chaperone function, suggesting that the structural modification dissected the dual targeting effects of the compound. The most potent compounds 20 and 22 exhibited strong cell proliferation inhibitory activities at subnanomolar concentration against 60 human cancer cell lines conducted by Developmental Therapeutic Program at the National Cancer Institute and represented promising candidates for anticancer drug development.
机译:热休克蛋白27(Hsp27)是一种伴侣蛋白,可响应包括抗癌化学疗法在内的各种应激刺激而增加其表达,从而使细胞得以存活并引起耐药性。我们先前鉴定了通过蛋白质组学方法与Hsp27和微管蛋白结合的先导化合物。当前研究中基于系统配体的优化显着提高了化合物的细胞生长抑制和细胞凋亡诱导活性。与先导化合物相比,一种新的衍生物显示出更好的抑制微管蛋白聚合的能力,但抑制Hsp27分子伴侣功能的活性降低,这表明该结构修饰消除了该化合物的双重靶向作用。最有效的化合物20和22在亚纳摩尔浓度下对国家癌症研究所的发展治疗计划进行的60种人类癌细胞系表现出强大的细胞增殖抑制活性,并代表了抗癌药物开发的有希望的候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号